Dimensional Fund Advisors LP Portage Biotech Inc. Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$1.09 - $2.65 $4,130 - $10,040	-3,789 Reduced 26.4%	10,565 $19,000
Q3 2023 Nov 09, 2023	SELL	$2.09 - $3.68 $5,561 - $9,792	-2,661 Reduced 15.64%	14,354 $29,000
Q1 2023 May 12, 2023	SELL	$2.6 - $7.2 $3,408 - $9,439	-1,311 Reduced 7.15%	17,015 $52,000
Q4 2022 Feb 09, 2023	BUY	$4.42 - $150.6 $11,713 - $399,090	2,650 Added 16.9%	18,326 $96,000
Q3 2022 Nov 10, 2022	BUY	$6.81 - $136.4 $106,753 - $2.14 Million	15,676 New	15,676 $107,000

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $69.3M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.